Companies: 10,795·Total market cap: $144.5T
Grifols, S.A.

Grifols, S.A.

GRFSNASDAQHealthcare● Active
$7.33
$-0.31(-4.06%)
Market Cap$6.2B
P/E Ratio
52W High$11.14
52W Low$7.33
Overview
Foreign Private Issuer · Files 20-F / 6-K

Grifols, S.A. (GRFS) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001438569 · GRFS · NASDAQ · as of Jun 8, 2026

Filing snapshot

457
Total Filings
6-K
Latest Form
2026-05-15
Most Recent
2011
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001438569 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-04-17
Fiscal Year End
Apr 17, 2026
Accession No.
0001104659-26-044901
Primary Document
grfs-20251231x20f.htm
Source: data.sec.gov · CIK 0001438569 · Accession 0001104659-26-044901

Latest Key Filings

6-KQuarterly Report
FORM 6-K
2026-05-15
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-14
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-07
View
20-FAnnual Report (Foreign Issuer)
FORM 20-F
2026-04-17
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-14
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-03-24
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-02-26
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-02-26
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-17
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-12
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-01-08
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2025-12-16
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2025-11-12
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2025-11-04
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2025-09-29
View
Showing 1–15 of 456 filingsForm 4 / 144 hidden· 457 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001438569  |  Exchange: NASDAQ · Healthcare

Grifols, S.A. (NASDAQ: GRFS) has submitted 457 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2011. As a Healthcare sector company with CIK 0001438569, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Grifols, S.A.'s most comprehensive regulatory disclosure. The most recent Grifols, S.A. 10-K was filed on 2026-04-17 for fiscal year ending 2026. Historical GRFS 10-K annual reports are available from 2008 through 2026.

Investors researching Grifols, S.A. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08

Frequently Asked Questions

GRFS SEC Filings · 8 questions

Grifols, S.A. (GRFS) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 457 filings and access original documents at no cost. Grifols, S.A.'s CIK is 0001438569.

GRFS SEC filingsGrifols, S.A. SEC documentsfind GRFS 10-K